NCT04026347终止不适用
An Evaluation of the Vesair® Bladder Control System for the Treatment of Stress Urinary Incontinence in Post-Menopausal Women
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 158
- 试验地点
- 49
- 主要终点
- Composite Endpoint
研究概览
简要总结
Single-blind, multicenter, randomized clinical trial of the Vesair Balloon in the treatment of Stress Urinary Incontinence in post-menopausal women
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
盲法说明
Subject and assessor blinded to randomization result
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Post-menopausal women with SUI for at least 12 months
- •Average of at least one leak per day
- •Failed non-invasive treatment
- •Willing to undergo cystoscopy and a minimum of 5 visits over one year
排除标准
- •BMI > 40.0
- •Last menstrual period within 12 months of enrollment
- •On birth control and/or oral hormone replacement therapy
- •Urge-predominant mixed incontinence
- •SUI due to intrinsic sphincter deficiency
- •Prior treatment with the Vesair Balloon
- •Prior medical, surgical or non-surgical treatment for SUI within 6 months of enrollment
- •Recurrent or recent (within the past 5 years) kidney stones
- •Recurrent or recent (within the past 3 months) Urinary Tract Infection
- •Stage 3 or higher cystocele (POP-Q)
- •Interstitial or follicular cystitis / painful bladder syndrome
- •Local genital infection
- •Artificial sphincter
- •Anatomic abnormalities which would interfere with device placement.
- •Visible blood in the urine
- •Uncontrolled bladder contractions / discomfort with bladder filling up to 300cc
- •History of cancer of the urinary tract
- •History of any cancer within the past two years (excluding non-melanoma skin cancers)
- •History of any cancer not (yet) treated with curable intent (excluding non-melanoma skin cancers)
- •Immunologically suppressed or immunocompromised
- •Undergoing pelvic radiation, pelvic fibrosis from previous pelvic radiation
- •Non ambulatory / unable to do simple pad weight testing exercises
- •On anticoagulation therapy with the exception of aspirin
- •History of mental illness requiring inpatient treatment
- •Neurological disease such as Parkinson's or multiple sclerosis
- •Uncontrolled diabetes (A1C > 9%)
- •Recent alcohol or drug abuse requiring treatment in the past year
- •Autoimmune or connective tissue disorders such as Marfan syndrome, Ehlers-Danlos or Myasthenia Gravis
- •Allergy to polyurethane or perfluorocarbons
结局指标
主要结局
Composite Endpoint
时间窗: 6 months
Pad weight + I-QOL
次要结局
- Episode Frequency(6 months)
- Pad Weight(6 months)
- I-QOL(6 months)
- Patient Global Impression of Improvement (PGI-I)(6 months)
研究者
研究点 (49)
Loading locations...
相似试验
终止
不适用
Spiration Valves Against Standard TherapyPulmonary Air LeaksNCT02382614Olympus Corporation of the Americas75
已完成
不适用
The Spiration Valve System for the Treatment of Severe EmphysemaEmpyhsemaPulmonary Disease, Chronic ObstructiveNCT01989182Olympus Corporation of the Americas107
已完成
3 期
Randomised Controlled Trial Comparing Tension-Free Vaginal Tape (TVT), Pelvicol & Autologous Slings for Stress Urinary Incontinence(SUI)Stress Urinary IncontinenceNCT01057550Abertawe Bro Morgannwg University NHS Trust201
已完成
不适用
Automatic Control of Pressure Support Ventilation in Surgical Intensive Care UnitsVentilator WeaningNCT00445289University Hospital Schleswig-Holstein300
招募中
不适用
Treatment of Urethral Stricture With Urethral Drug BallUrethral Stricture Less Than 2 cmNCT05812482Lepu Medical Technology (Beijing) Co., Ltd.150